HRAS and neoplasm: Among them 13% of patients had strong expression (more than 51% of the concentration of the studied protein in the tumor cell), 13% moderate expression (from 31 to 40% of the protein concentration), 19% had low expression of H-Ras oncoproteins (from 21 to 29% protein concentration).